Rising Chronic Diseases To Augment Enteral Nutrition Market Growth

Enteral Nutrition Market
Enteral Nutrition Market

Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient and Others), Form (Powder and Liquid), Age Group (Adults, and Pediatric), and Distribution Channel (Hospital Sales, Retail, and Online) by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Enteral Nutrition Market is estimated to be valued at US$ 7.2 billion in 2023 and is expected to exhibit a CAGR of 5.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Enteral Nutrition, also known as tube feeding or artificial food, is the usage of a special formula offered from a clinical instrument that goes into the stomach or small intestines. It permits people who can’t intake commonly to manage their weight and strength. The physician may suggest tube feeding if one cannot eat or cannot do it properly, for instance because of the head and neck tumor or its treatment, a brain and spinal cord wound such as stroke or ALS, or gastrointestinal tract issues. The physician would select a kind of tube, a particular feeding pump, and an enteral nutrition formula depending on the health, the size and location of the tube, and the digestive capacities and necessities.

Competitive Landscape:

Key players involved in the growth of global Enteral Nutrition Market are ABBOTT LABORATORIES, HORMEL FOODS CORPORATION, DANONE S.A., GLOBAL HEALTH PRODUCTS, INC., MEIJI HOLDINGS CO., LTD., FRESENIUS KABI AG, RECKITT BENCKISER GROUP PLC., NESTLE S.A, B. BRAUN MELSUNGEN AG, VICTUS, INC.

Market Key Drivers:

Increasing prevalence of chronic diseases such as cancer and neurological diseases is expected to boost the growth of global Enteral Nutrition for Market. For instance, as per GLOBOCAN, cancer is the second largest diseases across the globe, approximately 19.3 million people suffer from cancer cases across the globe.

Rising gastrointestinal diseases, diabetes and others are projected to propel the growth of global Enteral Nutrition Market. For instance, as per facts and figures around 4 out of every 10 adults across the globe suffer from gastrointestinal diseases.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Enteral Nutrition for Market due to the surge in pandemic. The rising cases has led to the closure of clinics, shift of doctors towards curing Covid-19 patients. Lack of beds, healthcare physician and appointments in hospital visits has impeded the market growth.

Key Takeaways:

The global Enteral Nutrition Market is anticipated to exhibit a CAGR of 5.5 % during the forecast period owing to the rising product launches and approvals. For instance, in May 2022, Abbott launched EleCare specialty amino acid-based formulas in kids and children who have serious food allergies or gastrointestinal diseases.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Enteral Nutrition for Market due to rise in F&B sector, increasing chronic diseases such as cancer, gastrointestinal diseases, diabetes, neurological diseases, rising product launches and approvals. For instance, as per the American Cancer Society, in 2022, around 1.9 million people in U.S suffer from cancer.

Comments

Popular posts from this blog

Vehicle-To-Vehicle (V2V) Communication; Used To Wirelessly Interchange Data Regarding Their Speed, Place, And Heading

Global Polyphenol Market Is Expanding Owing To Growing Development Of Polyphenol-Rich Products For Health Improvement

Global Ferrous Sulfate Market Is Anticipated To Witness High Growth Due To Growing Demand In The Water Treatment Segment And Increasing Applications In Cement And Agriculture